赛诺菲:度普利尤单抗大卖80亿美元,RSV单抗增长79%7月31日,赛诺菲公布2025H1业绩,上半年总营收198.89亿欧元(约218.00亿美元,按2025年平均汇率换算,1欧元=1.0961美元,下同),同比增长9.9%(按固定汇率计算,下同);研发投入37.17亿欧元(约40.74亿美元),占总营收的18.7%。从业务板块来看,免疫、罕见病、神经、肿瘤、疫苗以及其他类六大板块分别收入...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.